Published in Anticancer Drugs on September 01, 1996
Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology (2014) 1.04
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother (2015) 0.99
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol (2012) 0.94
Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol Oncol (2015) 0.87
The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev (2016) 0.77
Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients. Radiol Oncol (2016) 0.77
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res (1995) 1.85
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res (2001) 1.75
The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J (1998) 1.61
Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. Biophys J (2000) 1.59
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.55
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat (2011) 1.50
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res (2000) 1.19
Tumour blood flow changes induced by application of electric pulses. Eur J Cancer (1999) 1.17
Prognostic factors in the prediction of chronic wound healing by electrical stimulation. Med Biol Eng Comput (2001) 1.15
Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma (2007) 1.12
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res (2000) 1.11
Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer (1998) 1.10
Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties. Agents Actions (1993) 1.07
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng (2006) 1.05
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer (2002) 1.01
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res (2001) 0.99
The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistry (2001) 0.98
Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori (2000) 0.98
Microbial aetiology of community-acquired pneumonia in hospitalised patients. Eur J Clin Microbiol Infect Dis (1999) 0.97
Determination of the lipid bilayer breakdown voltage by means of linear rising signal. Bioelectrochemistry (2006) 0.97
Parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy in patients with peripheral vascular disease and in healthy volunteers. Ann Biomed Eng (2001) 0.96
Second-order model of membrane electric field induced by alternating external electric fields. IEEE Trans Biomed Eng (2000) 0.95
Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett (1997) 0.95
Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res (2000) 0.93
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry (2001) 0.93
Electric current density imaging of mice tumors. Magn Reson Med (1997) 0.92
Reproducibility of parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy and transcutaneous oximetry. Ann Biomed Eng (2000) 0.91
Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther (2011) 0.91
Reduced tumor oxygenation by treatment with vinblastine. Cancer Res (2001) 0.90
A reliable method of determining wound healing rate. Med Biol Eng Comput (2001) 0.89
Modelling of chronic wound healing dynamics. Med Biol Eng Comput (2000) 0.89
Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res (1998) 0.89
Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs (1998) 0.88
Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys (2000) 0.88
The killing activity of microwaves on some non-sporogenic and sporogenic medically important bacterial strains. J Hosp Infect (1991) 0.88
Improved photo-CIDNP methods for studying protein structure and folding. J Biomol NMR (2000) 0.87
Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent. Biotechniques (2000) 0.87
In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer (2003) 0.87
Theoretical evaluation of the distributed power dissipation in biological cells exposed to electric fields. Bioelectromagnetics (2000) 0.86
Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz. J Membr Biol (2010) 0.86
Calculation of the electrical parameters in electrochemotherapy of solid tumours in mice. Comput Biol Med (1998) 0.86
The temperature effect during pulse application on cell membrane fluidity and permeabilization. Bioelectrochemistry (2008) 0.85
Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. Anticancer Res (1999) 0.84
Efficient electrotransfection into canine muscle. Technol Cancer Res Treat (2008) 0.84
The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice. Gene Ther (2007) 0.84
Inhibition of SA-1 tumor growth in mice by human leukocyte interferon alpha combined with low-level direct current. Mol Biother (1990) 0.84
Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images. J Microsc (2010) 0.84
MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther (2010) 0.84
Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. J Pharm Biomed Anal (1997) 0.83
Electrochemotherapy of tumours. Curr Oncol (2009) 0.82
Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28. Cancer Gene Ther (2013) 0.81
Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer (2001) 0.81
Effect of hydralazine on interstitial fluid pressure in experimental tumours and in normal tissue. In Vivo (2001) 0.80
Human peripheral blood lymphocytes sensitised to PPD respond to in vitro stimulation with increased expression of CD69 and CD134 activation antigens and production of Th-1 type cytokines. Pflugers Arch (2000) 0.79
Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res (2001) 0.79
An algorithm for synchronization of in vivo electroporation with ECG. J Med Eng Technol (2005) 0.79
Blood perfusion of subcutaneous tumours in mice following the application of low-level direct electric current. Adv Exp Med Biol (1999) 0.78
Local changes in membrane potential intensify neutrophil oxidative burst. Physiol Chem Phys Med NMR (1997) 0.77
Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett (1993) 0.77
Modified cell proliferation due to electrical currents. Med Biol Eng Comput (1992) 0.77
Pulsed electric current enhances the phorbol ester induced oxidative burst in human neutrophils. FEBS Lett (1992) 0.77
In vivo administration of azithromycin affects lymphocyte activity in vitro. Antimicrob Agents Chemother (1993) 0.76
Electrochemotherapy of solid tumors--preclinical and clinical experience. Conf Proc IEEE Eng Med Biol Soc (2011) 0.76
Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results. Neoplasma (2005) 0.76
N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue. J Med Chem (1998) 0.76
Murine monoclonal antibodies directed against human recombinant Macrophage Migration Inhibitory Factor. Pflugers Arch (2000) 0.76
Cell-mediated immune response to high-passage Borrelia spirochetes in C57bl/6 mice is strictly dependent on antigen specificity. Microbiol Res (2001) 0.75
Use of nitric acid in sample pretreatment for determination of trace elements in various biological samples by ETAAS. J Pharm Biomed Anal (2000) 0.75
Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma. Anticancer Drugs (1994) 0.75
Effects of vinblastine on cell membrane fluidity and the growth of SA-1 tumor in mice. Cancer Lett (1994) 0.75
The cell-mediated immune response to Borrelia afzelii, garinii and burgdorferi in C57BL/6 mice is dependent on antigen specificity. FEMS Immunol Med Microbiol (2000) 0.75
Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients. Transplant Proc (2005) 0.75
Effect of vinblastine on cell membrane fluidity in vinblastine-sensitive and -resistant HeLa cells. Cancer Lett (1998) 0.75
Acute infectious lymphocytosis caused by coxsackievirus B2. Pediatr Infect Dis J (1996) 0.75
Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors. Anticancer Drugs (1992) 0.75
The humoral and cellular immune response to a lipid attenuated pore-forming toxin from the sea anemone Actinia equina L. Toxicon (1994) 0.75